ERBB3 and melanoma: FoXD3, a transcription factor of HER3, can upregulate HER3 and increase the resistance to rapidly accelerated fibrosarcoma (RAF) inhibitors by activating PI3K/AKT signaling in melanoma cell lines and mouse xenograft models[175].